Organogenesis Holdings ORGOW 深 沪
等待开盘 12-16 09:30:00 美东时间
0.21
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.21
- 总市值 0
- 52周最高 0.21
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 0.21
- 委 比 0.00%
- 总股本 --
- 历史最高 0.21
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.21
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Market-Moving News for December 16th
RILY: 50% | B. Riley Financial shares are trading higher after the company reported better-than-expected Q2 financial results. ORGO: 24% | Organogenesis Holdings shares are trading higher after the company
52分钟前
Biggest stock movers Tuesday: RILY, ORGO, KYTX, RC, LWLG and more
U.S. stock futures retreated Tuesday as investors adopted a cautious stance ahead of November’s employment data, a key indicator for the labor market’s health. Here are some of Tuesday's biggest stock...
今天 18:17
Organogenesis Holdings Completes Type-B Meeting With FDA Resulting In Confirmation To Initiate Rolling BLA For ReNu Planned Before December End
Clinical Development Program Appropriate for Rolling BLA Submission Expected by the End of 2025CANTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative
今天 05:28
BTIG Maintains Buy on Organogenesis Holdings, Raises Price Target to $9
BTIG analyst Ryan Zimmerman maintains Organogenesis Holdings (NASDAQ:ORGO) with a Buy and raises the price target from $7 to $9.
11-20 20:51
Organogenesis Holdings Reports Record Revenue, Raises Guidance
Organogenesis Holdings ( ($ORGO) ) has released its Q3 earnings. Here is a brea...
11-07 13:54
Organogenesis Holdings Raises FY2025 Net product revenue Guidance from $480.000M-$510.000M to $500.000M-$525.000M.
Organogenesis Holdings (NASDAQ:ORGO) raises FY2025 Net product revenue outlook from $480.000 million-$510.000 million to $500.000 million-$525.000 million.
11-07 07:12
Organogenesis Holdings shares are trading higher after the company reported better-than-expected Q3 financial results.
Organogenesis Holdings shares are trading higher after the company reported bet...
11-07 06:00
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Organogenesis Applauds CMS’s Significant Step In Payment Reform
Organogenesis Holdings Inc. congratulates CMS on its payment reform for skin substitutes under the 2026 Physician Fee Schedule, which finalizes FDA classifications and introduces a per square centimeter payment methodology. The company believes this will enhance access to PMA products and reduce abuse in the current system. With over 40 years of leadership and a diverse evidence-based portfolio covering all FDA categories, Organogenesis is well-p...
11-03 18:10
Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Organogenesis Holdings Inc. granted inducement awards to its new Chief Technology Officer, Michael Catarina, including 82,542 NSOs and 47,962 RSUs, vesting over four years. The NSOs have an exercise price of $4.17 per share. These awards were made under Nasdaq Listing Rule 5635(c)(4) and align with the 2018 Equity Incentive Plan terms.
10-31 20:05
